Yuting Wu

发表

Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease.

Cheng Huang, Xiao-ming Meng, Jun Li, 2015, Current pharmaceutical design.

Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.

Cheng Huang, Xiao-ming Meng, Jun Li, 2015, Toxicology and applied pharmacology.

SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion.

Cheng Huang, Xiao-ming Meng, Jun Li, 2018, Toxicology letters.

Role of NLRC5 in progression and reversal of hepatic fibrosis.

Cheng Huang, Xiao-ming Meng, Jun Li, 2016, Toxicology and applied pharmacology.

NLRC5: A paradigm for NLRs in immunological and inflammatory reaction.

Jun Li, Yuting Wu, TianLu Shi, 2019, Cancer letters.

Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis.

Taotao Ma, Cheng Huang, Xiao-ming Meng, 2014, Biochimica et biophysica acta.

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells

Cheng Huang, Xiao-ming Meng, Jun Li, 2019, Molecular immunology.

Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target

Cheng Huang, Xiao-ming Meng, Jun Li, 2015, Tumor Biology.

Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis

Taotao Ma, Cheng Huang, Xiao-ming Meng, 2017, Toxicology and applied pharmacology.

Deficiency of NLR family member NLRC5 alleviates alcohol induced hepatic injury and steatosis by enhancing autophagy of hepatocytes.

Cheng Huang, Yuting Wu, Jun Li, 2023, Toxicology and applied pharmacology.

ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner

M. Xiao, Yuting Wu, Xiaozhen Chen, 2023, Cell death discovery.